The board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited announced that Mr. Wang Chi has been appointed as the chief executive officer of the Company with effect from 10 May 2024. The biographical details of Mr. Wang are set out as follows: Wang Chi, aged 49, has more than 20 years of experience in medical and pharmaceutical industry. Mr. Wang joined Beijing Tong Ren Tang Pharmaceutical Company Limited, a subsidiary of China Beijing Tong Ren Tang Group Co.

Ltd., to serve as the general manager, and was appointed as a director of the Pharmaceutical Company in January 2023. Prior to joining Beijing Tong Ren Tang Group, Mr. Wang was the general manager of the Jiangzhong Food Therapy Company Limited and chairman and general manager of subsidiaries and various senior positions in Humanwell Healthcare (Group) Co. Ltd. Mr. Wang attained a bachelor's degree in Mechanical Manufacture and Design from Department of Mechanical Engineering of Wuhan University (formerly known as Wuhan University of Hydraulic and Electric Engineering) in 1996, and obtained a master's degree in Business Administration from Economics and Management School of Wuhan University in 2003, and then obtained a Ph.D. in Management from Economics and Management School of Wuhan University in 2011.

Mr. Wang shall hold office until the next following annual general meeting of the Company after his appointment and if re-elected by the shareholders of the Company thereat, will be subject to retirement by rotation and re-election at annual general meeting of the Company at least once every three years in accordance with the articles of association of the Company. The Board further announced that, due to the appointment of Mr. Wang as the chief executive officer of the Company, Mr. Chen Fei, currently an executive director, the acting chief executive officer and the executive deputy general manager of the Company, will no longer act as the acting chief executive officer of the Company with effect from 10 May 2024 and will remain as an executive director and the executive deputy general manager of the Company.